BOSTON UNIVERSITY MEDICAL CAMPUS
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study is a funding opportunity from BOSTON UNIVERSITY MEDICAL CAMPUS, up to 580505, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
Project Summary The path to effective treatment and prevention of Alzheimer's disease (AD) depends on disease detection that occurs before it is too late to reverse progression. Amyloid beta (Aß) is the widely accepted "gold standard" biomarker of AD and current methods for measuring this biomarker rely on positron…